Immune-checkpoint inhibitors in non-small cell lung cancer: a tool to improve patients ’ selection

We examined these factors, emerging from the results of currently available studies in non-small cell lung cancer (NSCLC), aiming to provide a useful and manageable tool which can help Oncologists in their everyday clinical practice.

Source: Critical Reviews in Oncology Hematology - June 23, 2018 Category: Cancer & Oncology Authors: Giuseppe Luigi Banna, Francesco Passiglia, Francesca Colonese, Stefania Canova, Jessica Menis, Alfredo Addeo, Antonio Russo, Diego Luigi Cortinovis Source Type: research